Glycemic control among type 2 diabetic patients attending the Family Medicine Health Center and the Diabetic Health Center in Erbil, Iraq: a comparative study

Ali Shakir Dauod

doi:10.15218/zjms.2018.043

Authors

Ali Shakir Dauod Department of Community Medicine, College of Medicine, Hawler Medical University, Erbil, Iraq.

DOI:

https://doi.org/10.15218/zjms.2018.043

Keywords:

Type 2 diabetes mellitus, Primary health care, Family medicine, Diabetes center; Glycemic control

Abstract

Background and objective: Type 2 diabetes mellitus constitutes a universal growing community health problem particularly in developing countries. This study aimed to determine and compare the rate of the glycemic control and other biochemical parameters of type 2 diabetic patients treated in a primary health center and the diabetic center.

Methods: A cross-sectional study was carried out on a sample of 300 adult patient’s aged ≥18 years with type 2 diabetes who attended Brayati family medicine center and the diabetic center in Erbil city during the period from the 1^stof January 2015 to the 28th of February 2016.

Results: The mean hemoglobin A1c among patients of the diabetes center was significantly higher than that among patients of the Brayati center (8.28% and 7.21%, respectively) (P <0.001) and the means of triglycerides, total cholesterol, and LDL were significantly higher among patients of the diabetes center compared with Brayati center (P <0.001). Half of the patients at Brayati center had controlled diabetes compared with only 24.7% of patients at the diabetes center (P <0.001), and 50% of the Brayati center sample had equal or more than three controlled risk factors compared with only one-quarter of the diabetes center sample (P <0.001). Logistic regression analysis showed that being a patient in Brayati center (compared with diabetes center) (P <0.001; OR = 3.1), diabetes duration of less than five years (P <0.001; OR = 3), and controlled lipid profile (P = 0.004; OR = 2.5) were significantly associated with diabetes control.

Conclusion: Type 2 diabetes can be effectively managed at primary health care, and good glycemic control can be achieved by a greater effort of the health care providers. Reorganizing primary care practice and shifting toward family medicine practice is necessary.

Metrics

Metrics Loading ...

References

International Diabetes Federation. IDF Diabetes Atlas. 6th ed. Brussels: IDF; 2013. (Accessed November 1, 2015, at: http://www.diabetesatlas.org/resources/how-to-cite.html).

Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 2011; 94(3):311–21.

Krentz AJ, Bailey CJ. Type 2 diabetes in practice, 2nd ed. London, UK: Royal Society of Medicine Press Ltd.; 2005.

Williams G, Pickup JC. The Handbook of Diabetes Paperback, 3rd ed. Oxford: Blackwell Publishing Ltd; 2004.

American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 2014; 37(Supplement 1):S81–90.

Spann SJ, Nutting PA, Galliher JM, Peterson KA, Pavlik VN, Dickinson LM, et al. Management of type 2 diabetes in the primary care setting: a practice-based research network study. Ann Fam Med 2006; 4(1):23–31.

Goyder EC, McNally PG, Drucquer M, Spiers N, Botha JL. Shifting of care for diabetes from secondary to primary care, 1990-5: review of general practices. BMJ 1998; 316(7143):1505.

Ho M, Marger M, Beart J, Yip I, Shekelle P. Is the quality of diabetes care better in a diabetes clinic or in a general medicine clinic? Diabetes Care 1997; 20(4):472–5.

de Fine Olivarius N, Beck-Nielsen H, Andreasen AH, Horder M, Pedersen PA. Randomised controlled trial of structured personal care of type 2 diabetes mellitus. BMJ 2001; 27;323(7319):970.

Martin JC, Avant RF, Bowman MA, Bucholtz JR, Dickinson JR, Evans KL, et al. The future of family medicine: a collaborative project of the family medicine community. Ann Fam Med 2004; 2(suppl 1):S3–32.

Daniel WW. Biostatistics: A Foundation for Analysis in the Health Sciences. 7th ed. New York: John Wiley & Sons Publishing Ltd; 1999.

Demirci H, Satman I, Çınar Y, Bilgel N. Essentials of Diabetes Care in Family Practice. In Diabetes Mellitus-Insights and Perspectives. Croatia: InTech Prepress, Novi Sad; 2013.

Al Balushi KA, Al-Haddabi M, Al-Zakwani I, Al Za’abi M. Glycemic control among patients with type 2 diabetes at a primary health care center in Oman. Prim Care Diabetes 2014; 8(3):239–43.

Khattab M, Khader YS, Al-Khawaldeh A, Ajlouni K. Factors associated with poor glycemic control among patients with type 2 diabetes. J Diabetes Complication 2010; 24(2):84–9.

Bi Y, Zhu D, Cheng J, Zhu Y, Xu N, Cui S, et al. The status of glycemic control: A cross-sectional study of outpatients with type 2 diabetes mellitus across primary, secondary, and tertiary hospitals in the Jiangsu province of China. Clin Ther 2010; 32(5):973–83.

Ismail IS, Nazaimoon WW, Mohamad WW, Letchuman R, Singaraveloo M, Pendek R, et al. Socioedemographic determinants of glycaemic control in young diabetic patients in peninsular Malaysia. Diabetes Res Clin Pract 2000; 47(1):57–69.

Leiter LA, Berard L, Bowering CK, Cheng AY, Dawson KG, Ekoé JM, et al. Type 2 diabetes mellitus management in Canada: is it improving? Can J Diabetes 2013; 37(2):82–9.

Arai K, Takai M, Hirao K, Matsuba I, Matoba K, Takeda H, et al. Present status of insulin therapy for type 2 diabetes treated by general practitioners and diabetes specialists in Japan: Third report of a cross‐sectional survey of 15,652 patients. J Diabetes Investig 2012; 3(4):396–401.

Reisig V, Reitmeir P, Döring A, Rathmann W, Mielck A. Social inequalities and outcomes in type 2 diabetes in the German region of Augsburg. A cross-sectional survey. Int J Public Health 2007; 52(3):158–65.

Rhodes DR, McFarland KF, Finch WH, Johnson AO. Speaking and interruptions during primary care office visits. Fam Med 2001; 33(7):528–32.

Hhadija B, Alla HF, Mehad HF, Rajaa M, Eman A, Bahaa A, et al. Prevalence of dyslipidemia and its associated factors among employees of primary health care centers, Jeddah, Saudi Arabia. Int J Med Sci Public Health 2016; 5(5):947–51.

Stolar M. Glycemic control and complications in type 2 diabetes mellitus. Am J Med 2010; 123(3):S3–11.

Shah BR, Hux JE, Laupacis A, Zinman B, Van Walraven C. Clinical inertia in response to inadequate glycemic control. Diabetes Care 2005; 28(3):600–6.

Lang VB, Marković BB, Kranjčević K. Family physician clinical inertia in glycemic control among patients with type 2 diabetes. Med Sci Monit 2015; 21:403–11.

Ahmad NS, Islahudin F, Paraidathathu T. Factors associated with good glycemic control among patients with type 2 diabetes mellitus. J Diabetes Investig 2014; 5(5):563–9.

Ozder A. Lipid profile abnormalities seen in T2DM patients in primary healthcare in Turkey: a cross-sectional study. Lipids Health Dis 2014; 13(1):183.